Evaluation of argyrophilic nucleolar organizer regions (AgNORs) in differentiated thyroid carcinoma as an indicator for disease recurrence

Oncology Reports

Volumn 7, Issue 4, 2000, Pages 853-857

  Kawasaki, Fumihiro ^a   Onoda, Naoyoshi ^a   Ishikawa, Tetsuro ^a   Ogawa, Yoshinari ^a   Ikeda, Katsumi ^a   Sugano, Seiji ^a   Kato, Yasuyuki ^a   Chung, Kosei Hirakawa Y S ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

AgNORs; Prognostic indicator; Thyroid cancer

Indexed keywords

ADENOCARCINOMA; ADULT; ARTICLE; CANCER INVASION; CANCER STAGING; CHROMOSOME NOR; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; MIDDLE AGED; MORTALITY; PAPILLARY CARCINOMA; PATHOLOGY; PREDICTION AND FORECASTING; PROGNOSIS; RECURRENT DISEASE; RISK FACTOR; THYROID TUMOR; TIME;

ADENOCARCINOMA, FOLLICULAR; ADULT; CARCINOMA, PAPILLARY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NUCLEOLUS ORGANIZER REGION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECURRENCE; RISK FACTORS; THYROID NEOPLASMS; TIME FACTORS;

EID: 0034219442     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.7.4.853     Document Type: Review

References (31)

1. Sugino K, Ito K, Mimura T, Ozaki O, Kawano M, Kitamura Y and Iwabuchi H: The enucleation of thyroid tumors indetermine before surgery as papillary thyroid carcinoma: should immediate repression be performed? Surg Today 24: 305-308, 1994.
2. Simon D, Goretzki PE, Witte J and Roeher HD: Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma. World J Surg 20: 860-866, 1996.
3. Kapp D, Livolsi VA and Sanders MM: Anaplastic carcinoma following well differentiated thyroid cancer. Etiological considerations. Yale J Biol Med 55: 521, 1982.
4. Bayer DD, Green SB, Dor P, Williams ED, Colon J, van Gilse H, Mayer M, Sylvester RJ and van Glabbeke M: A prognostic index for thyroid carcinoma: a study of EORTC thyroid cancer cooperative group. Eur J Cancer 15: 1033-1041, 1979.
5. Tuibana M, Schlumberger M, Rougier P, Laplanche A, Benhamou E. Gardet P, Caillou B, Travagli J and Parmentier C: Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 55: 794-804, 1985.
6. Cody B and Rossi R: An expanded view of risk-group definition in differentiated thyroid carcinoma. Cancer 55: 794-804, 1985.
7. Smith SA, Hay ID, Goellner JR, Ryan JJ and McConahey WM: Mortality from papillary thyroid carcinoma: a case-control study of 56 lethal cases. Cancer 62: 1382-1388, 1988.
8. Robbins J, Merino MJ, Boice JD, Ron E, Ain KB, Alexander HR, Norton JA and Reynolds J: Thyroid cancer: a lethal endocrine neoplasm. Ann Intern Med 115: 133-147, 1991.
9. Shah JP, Loree TR, Dharker D, Strong EW, Begg C and Vlamis X: Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surg 164: 658-661, 1992.
10. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR and Grant CS: Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114: 1050-1058, 1993.
11. Coburn MC and Wanebo HJ: Age correlates with increased frequency of high risk factors in elderly patients with thyroid cancer. Am J Surg 170: 471-475, 1995.
12. Moreno-Egea A, Rodriguez-Gonzales JM, Sola-Perez J, Soria-Cogollos T and Parrilla-Paricio P: Multivariate analysis of histopathlogical features as prognostic factors in patients with papillary thyroid carcinoma. Br J Surg 82: 1092-1094, 1995.
13. Noguchi M, Katev N and Miyazaki I: Controversies in the surgical management of differentiated thyroid carcinoma. Int Surg 81: 163-167, 1996.
14. Pasieka JL, Zedenius J, Auer G, Grimelius L, Hoeg A, Goeran W and Baeckdahl M: Addition of nuclear DNA content to the AMES risk-group classification for papillary thyroid cancer. Surgery 112: 1154-1160, 1992.
15. Dobashi Y, Sakamoto A, Sugimura H, Mernyei M, Mori M, Oyama T and Machinami R: Overexpression of p53 as a prognostic factor in human thyroid carcinoma. Am J Surg Pathol 17: 375-381, 1993.
16. Omura K, Nagasato A, Kanehira E, Kinesen H, Amaya S, Kimura K, Kajita T, Nozaki Y, Mizukami Y, Nonomura A and Watanabe Y: Retinoblastoma protein and proliferating-cell nuclear antigen expression as predictors of recurrence in well-differentiated papillary thyroid carcinoma. J Clin Oncol 15: 3458-3463, 1997.
17. Onoda N, Ishikawa T, Yoshikawa K, Sugano S, Kato Y, Sowa M and Hirakawa K-Chung YS: Telomerase activity in thyroid tumors. Oncol Rep 5: 1447-1451, 1998.
18. Okayasu I, Osakabe T, Fujiwara M, Fukuda H, Kato M and Oshimura M: Significant correlation to telomerase activity in thyroid papillary carcinoma with cell differentiation, proliferation and extrathyroidal extension. Jpn J Cancer Res 88: 965-970, 1997.
19. Fukan S and Hernandez-Verdun D: The nucleolus and the nucleolar onganizer regions (collected review). Biol Cell 56: 189-206, 1984.
20. Ploton D, Menager M, Jeannesson P, Himber G, Pigeon F and Adnet JJ: Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level. Histochem J 18: 5-14, 1986.
21. Crocker J and Nar P: Nucleolar organizer regions in lymphomas. J Pathol 151: 111-118, 1987.
22. Ishida T, Kaneko S, Akazawa K, Tateishi M, Sugio K and Sugimachi K: Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients. Cancer Res 53: 5000-5003, 1993.
23. Hall PA, Crocher J, Watts A and Stansfeld AG: A comparison of nuclear organizer region staining and Ki-67 immunostaining in non-Hodgkin's lymphoma. Histopathology 12: 373-381, 1988.
24. Kakeji Y, Korenaga D, Tsujitani S, Haraguchi M, Maehara Y and Sugimachi K: Predictive value of Ki-67 and argyrophilic organizer region staining for lymph node metastasis in gastric cancer. Cancer Res 51: 3503-3506, 1991.
25. Charpin C, Bonnier P, Piana L, Kouzhami H, Devictor B, Lavaut MN, Andrac L and Allasia C: Correlation of nucleolar organizer regions and nuclear morphometry assessed by automatic image analysis in breast cancer with aneuploidy, Ki-67 immunostaining, histopathologic grade and lymph node involvement Path Res Pract 188: 1009-1017, 1992.
26. Morita M, Kuwano H, Matsuda H, Moriguchi S and Sugimachi K: Prognostic significance of argyrophilic organizer regions in esophageal carcinoma. Cancer Res 51: 5339-5341, 1991.
27. Hehir K, Cronin KJ, Dervan PA, McCann A, Carney DN, Hederman WP and Heffernan SJ: Argylophilic organizer regions (AgNORs) as a prognostic indicator in breast carcinoma. IJMS 161: 112-115, 1992.
28. Eskelinen MJ, Lipponen PK, Collan Y and Syrjanen K: The role of nucleolar organizer regions as prognostic factors in breast cancer. Eur J Cancer 27: 989-992, 1991.
29. Ogawa Y, Chung YS, Nakata B, Kato Y, Yoshikawa K, Sowa M and Nishimori T: Evaluation of argyrophilic nucleolar organizer regions (AgNORs) in breast cancer. Ann Cancer Res Ther 3: 109-112, 1993.
30. Ogawa Y, Chung YS, Maeda K, Onoda N, Nishimori T, Kato Y and Sowa M: Evaluation of argyrophilic nucleolar organizer regions (AgNORs) in gastric cancer. Jpn J cancer Clin (in Japanese with English abstract) 39: 991-994, 1993.
31. Hedinger C, Williams ED and Sobin LH: Histologic typing of thyroid tumors. Vol. 11. 2nd edition. World Health Organization, Springer-Verlag, Berlin, pp5-18, 1993.